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Willingness to spend timeAbstract Implementation of pharmaceutical care (PC) in Poland is of great importance to
patients, who, on the one hand, often follow complex pharmacological treatment regimens recom-
mended by several physicians of different specialties, and, on the other, take up the decision on self-
treatment due to availability of OTC medications. The aim of the present study was to assess the
opinion of both patients and physicians about implementation of PC service in Polish community
pharmacies.
A cross sectional study was carried out from September 2009 to September 2010 by a pharmacist
(author of the study) on the basis of an anonymous questionnaire, where demand of physicians
(n= 104) and patients (n= 202) for implementation of PC in a community pharmacy was
assessed. The study was planned to determine the relationship between implementation of PC, cost
and time of this service and patients’ and physicians’ socio-economic information.
Responding patients (85.64%) and physicians (76.92%) unanimously conﬁrmed the need for
implementation of PC. Most people convinced of the service implementation were 88.89% of phy-
sicians under the age of 35 and all the respondents were over 65 years of age (p= 0.027), just as
93.33% with service lesser than 5 years and 73.68% of respondents working a maximum of 20 years
(p= 0.023). Mainly according to 90.00% of physicians with specialty in internal medicine and
92.59% of physicians of the group ‘‘Others’’ (p= 0.012), PC should be implemented in pharmacies.
Women more frequently than men reckoned that appointments with a pharmacist should last up toSimon).
538 M. Waszyk-Nowaczyk et al.15 min (p= 0.012). According to 77.78% of the youngest physicians and 83.33% of the oldest ones,
appointments should last from 5 to 15 min (p= 0.049), and a similar opinion was shared by
80.77% of physicians without specialty and 77.78% of physicians of the group ‘‘Others’’
(p= 0.0009). According to patients, the mean cost of the visit should be USD 7. Physicians most
often assessed the mean cost of the appointment at USD 14.
This study provides new data about implementation of PC in Poland. The increased patients’ and
physicians’ willingness to beneﬁt from this service provides pharmacists with opportunities to
develop PC in community pharmacies.
ª 2014 King Saud University. Production and hosting by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Transformations which affected health care in Poland in the last
few years, apart from some positive aspects for pharmaceutical
branches, such as very good supply or a wide range of available
medications, also contributed to exacerbation of the situation of
community pharmacies among other things by intensiﬁcation of
unhealthy competition. Aggressive advertising, breaking
pharmaceutical law and even dumping very often dominate
professional advice. It makes some pharmacists mainly entre-
preneurs whosemain aim is to obtain income essential for main-
taining a pharmacy and earning proﬁt.What is more, in the case
of an insufﬁcient number of employees, pharmacists are
compelled to carry out non-speciﬁc administration duties, not
related toworkwith patients, which could be fulﬁlled by persons
without pharmaceutical education (Waszyk-Nowaczyk and
Simon, 2009). Similar problems have also been noted in other
countries (Hughes et al., 2010; Perraudin et al., 2011; Van den
Brink et al., 2012; Ibrahim and Scott, 2013).
A pharmacist is the ﬁrst person addressed by a patient with
a health problem due to often an impossible immediate contact
with a physician within the service of the National Health
Fund in Poland (Jasin´ska and Orszulak-Michalak, 2009).
Additionally, the mean time of a physician’s advice is decreas-
ing, so a medical examination of a patient is often followed by
only providing the patient with a prescription and some eva-
sive information (Kwilecki, 2009). Therefore patients often
seek advice in community pharmacies, and frequently omit a
visit to a physician’s ofﬁce. Implementation of PC is of great
importance to patients, who, on the one hand, often follow
complex pharmacological treatment regimens prescribed by
several physicians of different specialties, and, on the other
one, due to aggressive advertising, take up a decision on self-
treatment (Szalonka and Sikorska, 2007; Modig and Kristens-
son, 2009; Wong et al., 2011; Chan et al., 2013). PC provides
an opportunity to establish close cooperation between a phar-
macist and a physician to ensure optimal pharmacotherapy
conditions of a given patient to avoid problems of polyprag-
masy, and also offers the possibility of cost reduction resulting
from reimbursement of medications dispensed in pharmacies
(Al Mazroui et al., 2009; Onda et al., 2009; Westerlund and
Marklund, 2009; Niquille et al., 2010; Santos et al., 2010;
Krass et al., 2011; Waszyk-Nowaczyk and Simon, 2011).
Appropriate cooperation between a physician, a pharmacist
and a patient should also enhance the prestige of the pharma-
cist profession in Poland. Hence research was carried out
determining opinions of both patients and physicians about
implementation of PC service in community pharmacies. The
study was planned to establish the relationship between imple-mentation of PC, cost and time of this service and age, sex, and
education of patients as well as age, sex, specialty, profes-
sional/scientiﬁc degree and length of service of physicians.2. Materials and methods
A cross sectional study was carried out from September 2009
to September 2010 by a pharmacist (the author of the present
study) on the basis of an anonymous questionnaire where phy-
sicians’ and patients’ demand for PC implementation in a com-
munity pharmacy was determined. The study included 104
physicians and 202 patients receiving services of four indepen-
dent Poznan community pharmacies. The questionnaire was
developed not only to examine physicians’ and patients’ will-
ingness to pay for the service, but also to generate information
to help pharmacists design PC in community pharmacies that
patients would pay for. This study used only some of the col-
lected information.
Respondents were asked to circle ‘yes’ or ‘no’ if they would
be willing to pay for PC. Persons exhibiting willingness to pay
for PC have been proposed with ﬁve sums which they would be
willing to pay for the offered service: USD 1, 2, 5, USD 5–20,
>20. It is associated with Polish insurance and accounting sys-
tem of pharmacy services with the National Health Fund,
where one lump sum amounts to approximately 2 dollars. Also
the time, which, in the opinion of a physician and a patient, a
pharmacist should spend on delivering PC was assessed. Three
categories were listed: less than 5 min, 5–15 min, more than
15 min. Socio-economic data included information about
age, sex, specialty, professional/scientiﬁc degree and length of
service of physicians, and age, sex and education of patients.
The study was approved by the ethics review board of Poznan
University of Medical Sciences.
The results were statistically analyzed with the use of Stat-
istica 8.0 application (StatSoft). In order to analyze relation-
ships between the traits, taking into account sample size and
frequency of analyzed categories of the examined traits, chi-
square test of independence (v2) was used in the case of a large
sample and a higher frequency of categories, and Fisher–
Freeman–Halton test for low expected frequencies. For all
the statistical analyses, a signiﬁcance level of 0.05 was used
to assess differences between groups.3. Results
In the research, 202 questionnaires were collected from
patients (Table 1) and 104 questionnaires from physicians
Table 1 Patients’ frequency distribution of the study.
Frequency (n) Percentage (%)
Age (years)














Table 2 Physicians’ frequency distribution of the study.
Frequency (n) Percentage (%)
Age (years)









Family medicine 21 20.19
Internal medicine 30 28.85
No specialty 26 25.00
Others: 27: 25.96:
Pediatrics 4 3.85
General surgery 4 3.85
Cardiology 4 3.85
Ophthalmology 3 2.88
Clinical oncology 3 2.88
Obstetrics and gynecology 3 2.88
Dermatology and venereology 2 1.93







PhD, MD 14 13.46
Prof., PhD, MD 2 1.92
Total 104 100.00
Length of service as a physician
Under 5 years 30 28.85
5–20 years 36 34.61
Over 20 years 38 36.54
Total 104 100.00
Figure 1 Patients’ willingness to implement PC in community
pharmacies, n= 202.
Figure 2 Physicians’ willingness to implement PC in community
pharmacies, n= 104.
Pharmaceutical care implementation 539(Table 2). About 60.00% of patients were 35–64 years old,
while women accounted for 75.74% of patients. Most of the
respondents had at least secondary education (83.17%). About
60.00% of physicians were women at the age of 35–64 years.
Predominant physicians’ specialties included internal medicine
(28.85%) and family medicine (20.19%). Most of the respond-
ing physicians had no scientiﬁc degree (84.62%). The length of
service of the physicians in the predominant group was longer
than 5 years (71.15%).
The research assessed the need for implementation of PC
and time and cost of an appointment with a pharmacist for
the purpose. The need was unanimously conﬁrmed by
85.64% of responding patients (Fig. 1) and 76.92% of physi-
cians (Fig. 2). The decision was independent of age, education
and sex of patients (Table 3). The results concerning opinions
of physicians are presented in Table 4. Most respondents con-
vinced of PC implementation were 88.89% of physicians under
the age of 35 and all the respondents over the age of 65
(p= 0.027), similarly as 93.33% of physicians with a length
of service shorter than 5 years and 73.68% of respondents
working for a maximum of 20 years (p= 0.023). According
to 90.00% of physicians with specialty in internal medicine
and 92.59% of physicians of the group ‘‘Others’’
(p= 0.012), implementation of PC in pharmacies should take
place.
Percentages of patients reckoned that the appointment
should last up to 5 min, and from 5 to 15 min were compara-
tive (43.07% vs 40.59%, Fig. 3). A considerable percentage of
physicians stated that an appropriate appointment time was at
least 5 min with a maximum of 15 min (67.31%, Fig. 4). Wo-
men more often than men stated that appointments with a
pharmacist should last up to 15 min (p= 0.012, Table 5). Ta-
ble 6 collates detailed information about physicians, where
77.78% of the youngest physicians and 83.33% of the oldest
ones reckoned that the visit should last from 5 to 15 min
(p= 0.049), similarly as 80.77% of physicians without spe-
cialty and 77.78% of physicians of the group ‘‘Others’’
(p= 0.0009).
The questionnaire also addressed the issue of paying for
PC. The mean cost of the appointment according to patients
should amount to about USD 7, and most of the respondents
Table 3 Patients’ opinions concerning implementation of PC
in community pharmacies and their sex, age and education.
Yes n (%) No n (%) p-Value
Age
Under 35 68 (89.47) 8 (10.53) 0.473
35–64 85 (82.52) 18 (17.48)
65+ 4 (17.39) 19 (82.61)
Total 157 (77.72) 45 (22.28)
Gender
Male 41 (83.67) 8 (16.33) 0.396
Female 135 (88.24) 18 (11.76)
Total 176 (87.13) 26 (12.87)
Education
Primary/vocational 26 (76.47) 8 (23.53) 0.407
Secondary 61 (84.72) 11 (15.28)
Student 8 (90.47) 4 (9.53)
Higher 49 (90.74) 5 (9.26)
Total 174 (86.14) 28 (13.86)
Table 4 Physicians’ opinions concerning implementation of
PC in community pharmacies and their sex, age and education.
Yes n (%) No n (%) p-Value
Age
Under 35 32 (88.89) 4 (11.11) 0.027*
35–64 42 (67.74) 20 (32.26)
65+ 6 (100.00) 0 (0.00)
Total 80 (76.92) 24 (23.08)
Gender
Male 33 (80.49) 8 (19.51) 0.635
Female 47 (74.60) 16 (25.40)
Total 80 (76.92) 24 (23.08)
Specialty
Family medicine 13 (61.90) 8 (38.10) 0.012*
Internal medicine 27 (90.00) 3 (10.00)
No specialty 18 (69.23) 8 (30.77)
Others 25 (92.59) 2 (7.41)
Total 83 (79.81) 21 (20.19)
Scientiﬁc/professional degree
MD 67 (76.14) 21 (23.86) 0.496
PhD, MD 12 (85.71) 2 (14.29)
Prof., PhD, MD 1 (50.00) 1 (50.00)
Total 80 (76.92) 24 (23.08)
Length of service as a physician
Under 5 years 28 (93.33) 2 (6.67) 0.023
5–20 years 24 (66.67) 12 (33.33)
Over 20 years 28 (73.68) 10 (26.32)
Total 80 (76.92) 24 (26.32)
* p< 0.05.
Figure 3 Patients’ willingness to spend time on delivering PC,
n= 202.
Figure 4 Physicians’ willingness to spend time on delivering PC,
n= 104.
540 M. Waszyk-Nowaczyk et al.indicated a sum of USD 1 (Fig. 5), more precisely – 41.86% of
persons aged from 35 to 64 years (p= 0.034) and 50.00% of
respondents with primary and occupational education
(p= 0.024, Table 7). Physicians most often determined mean
appointment cost at USD 14 by indicating a sum of the range
of USD 5–20 (Fig. 6). Table 8 shows that the sum was most
often stated by about 50.00% of persons over the age of 35(p= 0.005), by 55.56% of persons with specialty in family
medicine and by 66.67% of persons of the group without spe-
cialty (p= 0.024). The other patients (27.72%) and physicians
(30.77%) stated that PC should be a service reimbursed by
state (Figs. 5 and 6).
4. Discussion
The need for implementation of PC was conﬁrmed on the basis
of both patients’ and physicians’ opinions. The greatest accep-
tance was exhibited by internal medicine physicians, young
physicians without specialty and, what is especially important,
also by the group of the greatest length of service – more than
20 years. It probably results from many years of experience,
which is important for establishing appropriate cooperation
between physicians and pharmacists in Poland. The youngest
physicians conﬁrmed the need for joint work in the interdisci-
plinary team on safety of pharmacotherapy of a patient (Cer-
bin and Lulek, 2013). However, researches outside Poland
demonstrated no dependence on physician’s age (Azhar
et al., 2004; Matowe et al., 2006; Zaidan et al., 2011), and, even
in contrast to the results obtained in the study, it has been re-
ported that the higher length of service of a given physician,
the lower demands he makes on a pharmacist (Smith et al.,
2002). Data available in the literature indicate that patients’
experiences result in their positive attitude toward PC (Mont-
gomery et al., 2007) and make them expect wider and wider
range of the new service (Kassam et al., 2009). With time they
begin to notice the differences between ‘‘a friendly advice’’ and
substantiated PC, which, according to respondents, is much
more beneﬁcial (Montgomery et al., 2010; Robinson et al.,
2010). The need for implementation of PC in Poland has been
conﬁrmed by numerous researches carried out in the world,
proving health beneﬁts of PC to a patient. It is of particular
importance since many prescribed medications are not taken
according to a physician’s recommendations, which contrib-
utes to an increase in the number of hospitalized patients
and therefore increased expenditure on health care (Waserfall-
en et al., 2011). However, appropriate pharmacist’s interven-
Table 5 Patients’ opinions concerning time which a pharmacist should spend on delivering PC and their sex, age and education.
<5 min. n (%) 5–15 min n (%) 15 min. n (%) p-Value
Age
Under 35 32 (42.11) 32 (42.11) 12 (15.78) 0.890
35–64 42 (40.78) 46 (44.66) 15 (14.56)
65+ 9 (39.13) 9 (39.13) 5 (21.74)
Total 83 (41.09) 87 (43.07) 32 (15.84)
Gender
Male 31 (63.27) 13 (26.53) 5 (10.20) 0.012*
Female 96 (62.75) 39 (25.49) 18 (11.76)
Total 127 (62.87) 52 (25.74) 23 (11.39)
Education
Primary/vocational 14 (41.18) 10 (29.41) 10 (29.41) 0.149
Secondary 25 (34.72) 33 (45.83) 14 (19.45)
Student 16 (38.09) 1 9 (45.24) 7 (16.67)
Higher 28 (51.85) 24 (44.44) 2 (3.71)
Total 83 (41.09) 86 (42.57) 33 (16.34)
* p< 0.05.
Table 6 Physicians’ opinions concerning time which a pharmacist should spend on delivering PC and their sex, age and education.
<5 min. n (%) 5–15 min n (%) 15 min. n (%) p-Value
Age
Under 35 6 (16.67) 28 (77.78) 2 (5.55) 0.049*
35–64 9 (14.52) 34 (54.84) 19 (30.64)
65+ 1 (16.67) 5 (83.33) 0 (0.00)
Total 16 (15.39) 67 (64.42) 21 (20.19)
Gender
Male 10 (24.39) 27 (65.85) 4 (9.76) 0.062
Female 5 (7.94) 42 (66.67) 16 (25.39)
Total 15 (14.42) 69 (66.35) 20 (19.23)
Specialty
Family medicine 5 (23.81) 13 (61.91) 3 (14.28) 0.0009*
Internal medicine 2 (6.67) 13 (43.33) 15 (50.00)
No specialty 3 (11.54) 21 (80.77) 2 (7.69)
Others 6 (22.22) 21 (77.78) 0 (0.00)
Total 16 (15.38) 68 (65.39) 20 (19.23)
Scientiﬁc/professional degree
MD 12 (13.64) 58 (65.91) 18 (20.45) 0.644
PhD, MD 4 (28.57) 9 (64.29) 1 (7.14)
Prof., PhD, MD 0 (0.00) 2 (100.00) 0 (0.00)
Total 16 (15.38) 69 (66.35) 19 (18.27)
Length of service as a physician
Under 5 years 4 (13.33) 24(80.00) 2(6.67) 0.087
5–20 years 6 (16.67) 19(52.78) 11(30.55)
Over 20 years 5 (13.16) 23 (60.53) 10 (26.31)
Total 15 (14.42) 66 (63.46) 23 (22.12)
* p< 0.05.
Figure 5 Patients’ willingness to pay for PC, n= 202.
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Table 7 Patients’ opinions concerning paying for PC and their sex, age and education.
1$ n (%) 2$ n (%) 5$ n (%) 5–20$ n (%) 20$ n (%) p-Value
Age
Under 35 7 (23.22) 6 (20.00) 8 (26.67) 4 (13.33) 5 (16.67) 0.034*
35–64 18(41.86) 8 (18.61) 11 (25.58) 4 (9.30) 2 (4.65)
65+ 4 (26.67) 4 (26.67) 0 (0.00) 7 (46.66) 0 (0.00)
Total 29 (32.95) 18 (20.45) 19 (21.59) 15 (17.05) 7 (7.96)
Gender
Male 12 (42.86) 5 (17.86) 5 (17.86) 3 (10.71) 3 (10.71) 0.804
Female 21 (35.00) 11 (18.33) 16 (26.67) 8 (13.33) 4 (6.67)
Total 33 (37.50) 16 (18.18) 21 (23.86) 11 (12.50) 7 (7.96)
Education
Primary/vocational 6 (50.00) 1 (8.33) 1 (8.33) 4 (33.33) 0 (0.00) 0.024*
Secondary 15 (46.87) 4 (12.50) 6 (18.75) 5 (15.63) 2 (6.25)
Student 2 (12.50) 1 (6.25) 7 (43.75) 3 (18.75) 3 (18.75)
Higher 8 (28.57) 12 (42.86) 5 (17.86) 1 (3.57) 2 (7.14)
Total 31 (35.23) 18 (20.45) 19 (21.59) 13 (14.77) 7 (7.96)
* p< 0.05.
Figure 6 Physicians’ willingness to pay for PC, n= 104.
Table 8 Physicians’ opinions concerning paying for PC and their sex, age and education.
1$ n (%) 2$ n (%) 5$ n (%) 5–20$ n (%) 20$ n (%) p-Value
Age
Under 35 0 (0.00) 1 (6.25) 2 (12.50) 6 (37.50) 7 (43.75) 0.005*
35–64 0 (0.00) 0 (0.00) 4 (12.90) 16 (51.61) 11 (35.49)
65+ 0 (0.00) 0 (0.00) 0 (0.00) 5 (50.00) 5 (50.00)
Total 0 (0.00) 1 (1.75) 6 (10.53) 27 (47.37) 23 (40.35)
Gender
Male 0 (0.00) 1 (4.00) 2 (8.00) 15 (60.00) 7 (28.00) 0.877
Female 0 (0.00) 0 (0.00) 5 (15.63) 9 (28.12) 18 (56.25)
Total 0 (0.00) 1 (1.75) 7 (12.28) 24 (42.11) 25 (43.86)
Specialty
Family medicine 0 (0.00) 0 (0.00) 1 (11.11) 5 (55.56) 3 (33.33) 0.024*
Internal medicine 0 (0.00) 0 (0.00) 2 (10.00) 9 (45.00) 9 (45.00)
No specialty 0 (0.00) 0 (0.00) 1 (8.33) 8 (66.67) 3 (25.00)
Others 0 (0.00) 1 (6.25) 3 (18.75) 7 (43.75) 5 (31.25)
Total 0 (0.00) 1 (1.75) 7 (12.28) 29 (50.88) 20 (35.09)
Scientiﬁc/professional degree
MD 0 (0.00) 1 (2.27) 5 (11.36) 21 (47.73) 17 (38.64) 0.663
PhD, MD 0 (0.00) 0 (0.00) 1 (8.33) 8 (66.67) 3 (25.00)
Prof., PhD, MD 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) 1(100.00)
Total 0 (0.00) 1 (1.75) 6 (10.53) 29 (50.88) 21 (36.84)
Length of service as a physician
Under 5 years 0 (0.00) 1 (6.67) 3 (20.00) 6 (40.00) 5 (33.33) 0.221
5–20 years 0 (0.00) 0 (0.00) 1 (5.26) 10 (52.63) 8 (42.11)
Over 20 years 0 (0.00) 0 (0.00) 3 (13.04) 13 (56.52) 7 (30.44)
Total 0 (0.00) 1 (1.75) 7 (12.28) 29 (50.88) 20 (35.09)
* p< 0.05.
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Pharmaceutical care implementation 543tion enables to prevent medication problems, resulting in
obtaining right effects of prescribed pharmacotherapy (Lee-
mans et al., 2003; Van Mil et al., 2004; Williams et al.,
2008). According to Szalonka studies (2010), half of respond-
ing physicians determined the actual odds in favor of PC
implementation, and the most considerable obstacle indicated
by respondents was lack of a consistent computer application
and inappropriate system of communication between physi-
cians and pharmacists (Szalonka, 2010).
Patients, just as physicians, stated that a PC appointment
should last up to 15 min. Women were interested in a longer
time of the appointment, which was indicated also by two phy-
sician groups: of the physicians with a short length of service
and of those with the longest service. Scientiﬁc researches con-
ﬁrm that a pharmacist spends an average of up to 15 min per
patient on consulting medication problems (Campbell and
Saulie, 1998; Look et al., 2012). However, it is disturbing that
the time of the appointment indicated by half of the respon-
dents in the questionnaire was up to 5 min. The situation
may result from unawareness as well as from misunderstand-
ing of PC principles. The reason is that such time is insufﬁcient
for delivering the service as it only allows to provide essential
information, e.g., information concerning OTC medications
taken (Hong et al., 2010).
On the basis of the conducted research, it was determined
that about 43.56% of patients and 54.81% of physicians indi-
cated the need for paying for the service. Evaluation of PC ser-
vice was carried out and, in patients’ opinions, the averaged
value amounted to USD 7, and, in physicians’ opinion, it was
USD 14. About 1/3 of examined patients and physicians indi-
cated that the service should be reimbursed. A study by Dryja
et al. conﬁrms that patients in Poland are aware of the costs of
the care, and reckon that a pharmacist should receive additional
payment at amaximumofUSD7and theNationalHealthFund
should be the payer (Dryja et al., 2011). Also Skowron in her pa-
per noted that over half of responding patients were willing to
pay for the visit USD 2–3, and 31.00% of respondents indicated
a sum of USD 4–7. The ﬁgure was not dependent on obtained
income (Skowron, 2011). It was observed in the USA in 1994
that 20.00%of patients were inclined to pay a sum from 50 cents
to USD 1.5 for a consulting service concerning used OTC med-
ications (Gore and Madhavan, 1994). However, according to a
study conducted several years later, the interest in paying for
pharmaceutical services has been growing and reached
55.00%support, whileUSD5andmorewas indicated as an ade-
quate level of payment (Hong et al., 2010). Wang et al. in their
paper found that the service of Medication Management Ther-
apy is economically viable when a pharmacist’s salary ranges
from USD 30–100 an hour (Wang et al., 2011).
This study indicates that implementation of PC is expected
in the Polish reality. However, there are still problems with
understanding the idea of good pharmacy practice and PC.
Also the realities of everyday work of a pharmacist are an
obstacle, where there is no enactment of the Polish Pharmacist
Law, sources of service ﬁnancing, appropriate place for a talk
with a patient and no additional staff hired in a pharmacy
(Skowron, 2011).
The limitation of this study is the study sample because it is
not representative of the population of both patients and phy-
sicians. The study sample consisted of patients and physicians
in Poznan. Thus, the results may not be generalizable to pop-
ulations other than the study sample. The patients’ and physi-cians’ willingness to pay for PC was a subjective opinion of
respondents not an actual transaction data. Surveyed may
not actually pay for PC visit.
5. Conclusion
There is little evidence from Polish studies so this investigation
supplies new data about implementation PC in Poland. The in-
creased patients’ and physicians’ willingness to beneﬁt from
this service provides pharmacists with opportunities to develop
PC in community pharmacies.
The results of the study assure positive evidence to support
PC. It is expected by patients and physicians in the opportu-
nity of individualized and controlled pharmacotherapy in close
cooperation with pharmacists. Future investigation is needed
to understand how to better organize and ﬁnance these services
in Poland.
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